Enhancing CAR T-cell therapies against solid tumors: Mechanisms and reversion of resistance

Chimeric antigen receptor (CAR) T-cell therapy, belonging to adoptive immune cells therapy, utilizes engineered immunoreceptors to enhance tumor-specific killing. By now new generations of CAR T-cell therapies dramatically promote the effectiveness and robustness in leukemia cases. However, only a f...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yue, Xu, Guotai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773088/
https://www.ncbi.nlm.nih.gov/pubmed/36569859
http://dx.doi.org/10.3389/fimmu.2022.1053120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773088/
https://www.ncbi.nlm.nih.gov/pubmed/36569859
http://dx.doi.org/10.3389/fimmu.2022.1053120

Ejemplares similares